GI
LUCD icon

GAMMA Investing’s Lucid Diagnostics LUCD Stock Holding History

GAMMA Investing’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152 Sell
142
-752
-84% -$811 ﹤0.01% 4103
2026
Q1 		$1.03K Buy
894
+752
+530% +$957 ﹤0.01% 3833
2025
Q4 		$155 Buy
+142
New +$159 ﹤0.01% 4025

Other funds holding LUCD

SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's LUCD Position: Q2 2026 in Review

GAMMA Investing reduced its Lucid Diagnostics (LUCD) stake by 84% in Q2 2026, selling an estimated $811 and leaving 142 shares worth $152. The position accounts for ﹤0.01% of the portfolio, ranked #4103.

GAMMA Investing first reported a position in LUCD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.03K in Q1 2026. 8 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • GAMMA Investing held 142 shares of Lucid Diagnostics worth $152 as of Q2 2026.
  • GAMMA Investing sold 752 Lucid Diagnostics shares in Q2 2026, an estimated $811.
  • Lucid Diagnostics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4103 holding.
  • GAMMA Investing first reported a position in Lucid Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • GAMMA Investing's Lucid Diagnostics position peaked at $1.03K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.